Acetylsalicylic Acid

Adenomas

National Cancer Institute (NCI)Phase 3Dormant

BB

70/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 58/ 100
Competitive Position: 95/ 100

Competitive context

0 Active assets in the Adenomas cohort.

Asset / Sponsor	Phase	Rating
MARBLE DUST Colotech A/S	Phase 3	BB
MACROGOLS Korea University Anam Hospital	Phase 3	BB
PEG-Ascorbate Korea University Anam Hospital	Phase 3	BB
SODIUM PICOSULFATE HYDRATE Korea University Anam Hospital	Phase 3	BB
Spmc 2 Korea University Anam Hospital	Phase 3	BB

View all 17 →

Same molecule, other indications

Acetylsalicylic Acid is also rated in:

myocardial infarctionDormant

A

Indicative ·

83 / 100

coronary artery disorderDormant

BBB

Indicative ·

79 / 100

cardiovascular disorderDormant

BBB

Indicative ·

78 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.